Reviva Pharmaceuticals Holdings's total assets for Q2 2024 were $8.05M, a decrease of -40.34% from the previous quarter. RVPH total liabilities were $14.09M for the fiscal quarter, a -5.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.